Reference Article

from Wikipedia, the free encyclopedia

Embryonic stem cell

Embryonic stem cells (ESCs) are stem cells derived from the undifferentiated inner mass cells of a human embryo.

Embryonic stem cells are pluripotent, meaning they are able to grow (i.e. differentiate) into all derivatives of the three primary germ layers: ectoderm, endoderm and mesoderm.

In other words, they can develop into each of the more than 200 cell types of the adult body as long as they are specified to do so.

Embryonic stem cells are distinguished by two distinctive properties: their pluripotency, and their ability to replicate indefinitely.

ES cells are pluripotent, that is, they are able to differentiate into all derivatives of the three primary germ layers: ectoderm, endoderm, and mesoderm.

These include each of the more than 220 cell types in the adult body.

Pluripotency distinguishes embryonic stem cells from adult stem cells found in adults; while embryonic stem cells can generate all cell types in the body, adult stem cells are multipotent and can produce only a limited number of cell types.

Additionally, under defined conditions, embryonic stem cells are capable of propagating themselves indefinitely.

This allows embryonic stem cells to be employed as useful tools for both research and regenerative medicine, because they can produce limitless numbers of themselves for continued research or clinical use.

Because of their plasticity and potentially unlimited capacity for self-renewal, ES cell therapies have been proposed for regenerative medicine and tissue replacement after injury or disease.

Diseases that could potentially be treated by pluripotent stem cells include a number of blood and immune-system related genetic diseases, cancers, and disorders; juvenile diabetes;

Parkinson's; blindness and spinal cord injuries.

Besides the ethical concerns of stem cell therapy, there is a technical problem of graft-versus-host disease associated with allogeneic stem cell transplantation.

However, these problems associated with histocompatibility may be solved using autologous donor adult stem cells, therapeutic cloning, stem cell banks or more recently by reprogramming of somatic cells with defined factors (e.g. induced pluripotent stem cells).

Other potential uses of embryonic stem cells include investigation of early human development, study of genetic disease and as in vitro systems for toxicology testing.

Note: This article excerpts material from the Wikipedia article "Embryonic stem cell", which is released under the GNU Free Documentation License.

See the following related content on ScienceDaily:


Related Videos

last updated on 2014-09-16 at 9:02 am EDT

The Pros and Cons of Banking Your Baby’s Stem Cells

The Pros and Cons of Banking Your Baby’s Stem Cells

Ivanhoe (Jan. 15, 2014) — Umbilical cord stem cell banking: it can be expensive and controversial, but for one family the decision to pursue cord stem cell banking saved their baby’s life. Check out the pros and cons of banking your baby’s stem cells.
Powered by NewsLook.com
Autism and Cord Blood Stem Cells: FDA Gives Green Lite for Groundbreaking Clinical Trial

Autism and Cord Blood Stem Cells: FDA Gives Green Lite for Groundbreaking Clinical Trial

MultiVu (Aug. 21, 2012) — Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world's largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
Powered by NewsLook.com
Future Organ Production a Possibility With 3D Stem Cell Printer

Future Organ Production a Possibility With 3D Stem Cell Printer

Reuters (Mar. 24, 2013) — For the first time scientists have printed human embryonic stem cells using a 3D printer. The Heriot-Watt University team's research could eventually lead to human organs being printed on demand and an end to animal drug testing. Jim Drury reports.
Powered by NewsLook.com
Stem Cell Therapy Takes Arthritis Treatment Into the Future

Stem Cell Therapy Takes Arthritis Treatment Into the Future

Reuters (Apr. 9, 2013) — Doctors at Emory University in the US are testing a new stem cell therapy for people with severe arthritis. They hope that by harvesting stem cells from a patient, the potent cells will regenerate and repair areas damaged by arthritis. Ben Gruber reports.
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins